Dennis L. Spangler

A comparison of the relative efficacy and clinical performance of olopatadine hydrochloride 0.1% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the conjunctival antigen challenge model

Gregg J. Berdy, Dennis L. Spangler, George Bensch et al. · Clinical Therapeutics · 2000 · 69 citations

Fumarate 0.025, Ocular Disease, Ophthalmology +8

Evaluation of the efficacy of olapatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen challenge model

Dennis L. Spangler, George Bensch, Gregg J. Berdy · Clinical Therapeutics · 2001 · 62 citations

Ocular Disease, Allergy, Ophthalmology +7

Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models

Dennis L. Spangler, Mark B. Abelson, Andrew Ober et al. · Clinical Therapeutics · 2003 · 53 citations

Allergy, Ophthalmology, Allergy Medicine +9

Comparison of the efficacy of combined fluticasone propionate and olopatadine versus combined fluticasone propionate and fexofenadine for the treatment of allergic rhinoconjunctivitis induced by conjunctival allergen challenge

B.Q. Lanier, Mark B. Abelson, William E. Berger et al. · Clinical Therapeutics · 2002 · 38 citations

Asthma, Allergy, Ophthalmology +9

Efficacy of Once-Daily Olopatadine 0.2% Ophthalmic Solution Compared to Twice-Daily Olopatadine 0.1% Ophthalmic Solution for the Treatment of Ocular Itching Induced by Conjunctival Allergen Challenge

Mark B. Abelson, Dennis L. Spangler, Arthur B. Epstein et al. · Current Eye Research · 2007 · 24 citations

Asthma, Ocular Disease, Allergy Medicine +18